Bioceres Crop Solutions Corp. (BIOX) stock
BIOXNasdaqAgricultural ChemicalsFiscal year ends June 30
$0.20−0.01 (-4.90%)
Close on Nov 16, 2026Market cap $12.74MP/E –Yield –
Bioceres Crop Solutions operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Bioceres Crop Solutions's operating income for the twelve months ending Dec 31, 2025 was $11.04M, down 76.4% year over year. For fiscal 2026 it was -$23.41M, down 454.8% from the year before. The highest annual figure on record is $54.18M in fiscal 2023.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$23.41M | -454.8% |
| FY2025 | Jun 30, 2025 | $6.60M | -87.3% |
| FY2024 | Jun 30, 2024 | $52.13M | -3.8% |
| FY2023 | Jun 30, 2023 | $54.18M | +35.9% |
| FY2022 | Jun 30, 2022 | $39.87M | +3.9% |
| FY2021 | Jun 30, 2021 | $38.38M | -1.9% |
| FY2020 | Jun 30, 2020 | $39.15M | +22.0% |
| FY2019 | Jun 30, 2019 | $32.09M | +15397.2% |
| FY2016 | Dec 31, 2016 | $207.04K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $7.52M | -47.6% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $7.21M | +204.3% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$4.62M | -127.5% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $933.21K | -92.9% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $14.36M | -14.7% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $2.37M | -55.3% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $16.80M | +229.0% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $13.20M | -55.8% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $16.84M | +659.0% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $5.29M | -68.8% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $5.11M | -48.8% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $29.87M | +1290.8% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $2.22M | -87.5% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $16.99M | +47.4% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $9.98M | -49.0% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $2.15M | -88.7% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $17.70M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $11.53M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $19.56M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $19.01M | – |
See a number that looks wrong?